BioMarin Pharmaceutical CEO: Substantial Profits Ahead | Mad Money | CNBC CNBC Television 6:57 5 years ago 999 Далее Скачать
BioMarin CEO expects 'substantial' profitability after FDA approval of hemophilia drug CNBC Television 7:25 5 years ago 2 257 Далее Скачать
BioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money | CNBC CNBC 5:19 6 years ago 3 044 Далее Скачать
BioMarin Pharmaceutical CEO: Close to a Cure? | Mad Money | CNBC CNBC 6:01 7 years ago 1 240 Далее Скачать
BioMarin CEO Jean-Jacques Bienaimé: Pipeline Profits?| Mad Money | CNBC CNBC 5:55 9 years ago 1 906 Далее Скачать
BioMarin Pharmaceutical CEO: Orphan Opportunity? | Mad Money | CNBC CNBC 6:14 9 years ago 2 517 Далее Скачать
Biomarin Stock News Today (#BMRN) BioMarin | INVESTOR ALERT BioMarin Pharmaceutical Inc $BMRN Stock Levi & Korsinsky LLP 0:41 3 years ago 74 Далее Скачать
BioMarin CEO: Rare Treatments, High Costs | Mad Money | CNBC CNBC 7:17 7 years ago 2 487 Далее Скачать
$BMRN 💲💲 Biomarin Stock News Today (#BMRN) Biomarin Stock Investors Sue Biomarin Pharmaceutical Inc The Klein Law Firm 2:04 3 years ago 637 Далее Скачать
BioMarin (#BMRN) BMRN Stock 📉 SHAREHOLDERS In BioMarin Pharmaceutical Inc Securities Class Action The Gross Law Firm 1:57 3 years ago 1 295 Далее Скачать
Biomarin Stock News Today (#BMRN) BioMarin | INVESTOR ALERT BioMarin Pharmaceutical Inc $BMRN Stock Levi & Korsinsky LLP 1:43 3 years ago 428 Далее Скачать
BioMarin Pharmaceutical CEO on the company's drug pricing strategy CNBC Television 1:34 2 years ago 1 119 Далее Скачать
BioMarin CEO: Study results for hemophilia gene therapy are as 'good as we could hope' CNBC Television 2:41 2 years ago 2 017 Далее Скачать
Cramer: This biotech stock could be worth over $100 billion on an FDA approval CNBC Television 5:19 5 years ago 417 402 Далее Скачать
Institutional Investors Adjust Stakes in Viridian Therapeutics, BioMarin Pharmaceutical, and Xen ... NewsBOT Business 4:23 2 weeks ago 9 Далее Скачать
